Evidence map›Paper›PMID 34280241›Full record

ArticlePLoS pathogens2021

Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques.

Takushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, Trang Thi Thu Hau, Shigeyoshi Harada, Hiroshi Ishii, Sayuri Seki, Midori Nakamura-Hoshi, Midori Okazaki, Sachie Daigen and 12 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Beta testing the monkey model.Nature immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Takushi NomuraAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroyuki YamamotoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-0708-9373
Masako NishizawaAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Trang Thi Thu HauAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0001-5981-0284
Shigeyoshi HaradaAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroshi IshiiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Sayuri SekiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Midori Nakamura-HoshiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-4761-710X
Midori OkazakiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Sachie DaigenAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Ai Kawana-TachikawaAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-3082-5324
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0001-9147-1438
Naoko Iwata-YoshikawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Nozomi ShiwaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Shun IidaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0003-2258-9031
Harutaka KatanoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-5332-4434
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-3820-9542
Eun-Sil ParkDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Ken MaedaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Yuriko SuzakiManagement Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan.
Yasushi AmiManagement Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan.
Tetsuro MatanoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0003-3096-6749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infection presents clinical manifestations ranging from asymptomatic to fatal respiratory failure. Despite the induction of functional SARS-CoV-2-specific CD8+ T-cell responses in convalescent individuals, the role of virus-specific CD8+ T-cell responses in the control of SARS-CoV-2 replication remains unknown. In the present study, we show that subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques. Eight macaques were intranasally inoculated with 105 or 106 TCID50 of SARS-CoV-2, and three of the eight macaques were treated with a monoclonal anti-CD8 antibody on days 5 and 7 post-infection. In these three macaques, CD8+ T cells were undetectable on day 7 and thereafter, while virus-specific CD8+ T-cell responses were induced in the remaining five untreated animals. Viral RNA was detected in nasopharyngeal swabs for 10-17 days post-infection in all macaques, and the kinetics of viral RNA levels in pharyngeal swabs and plasma neutralizing antibody titers were comparable between the anti-CD8 antibody treated and untreated animals. SARS-CoV-2 RNA was detected in the pharyngeal mucosa and/or retropharyngeal lymph node obtained at necropsy on day 21 in two of the untreated group but undetectable in all macaques treated with anti-CD8 antibody. CD8+ T-cell responses may contribute to viral control in SARS-CoV-2 infection, but our results indicate possible containment of subacute viral replication in the absence of CD8+ T cells, implying that CD8+ T-cell dysfunction may not solely lead to viral control failure.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCD8-Positive T-LymphocytesCOVID-19Disease Models, AnimalFemaleHumansKineticsLymphocyte DepletionMacaca fascicularisMaleMonkey DiseasesRNA, ViralSARS-CoV-2Virus ReplicationAntibodies, NeutralizingAntibodies, ViralRNA, Viral

Identifiers

PMID34280241
PMCPMC8321216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.